Get the Stockscreener App
9.315
3.57%
-0.345
After Hours:
9.32
0.005
+0.05%
Theravance Biopharma Inc Stock (TBPH) Forecast
The Theravance Biopharma Inc (TBPH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.20, representing a +63.23% increase from the current price of $9.315. The highest analyst price target is $19.75, and the lowest is $10.66.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TBPH Price Target
Average 11.80
(+26.72% Upside)
Is Theravance Biopharma Inc (TBPH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.75 | Neutral |
| STOCH(9,6) | 66.69 | Neutral |
| STOCHRSI(14) | 32.41 | Neutral |
| MACD(12,26) | 0.0358 | Buy |
| ADX(14) | 20.01 | Neutral |
| William %R | -61.25 | Neutral |
| CCI(14) | -9.2708 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.4105
Sell
|
9.4807
Sell
|
| MA20 |
9.5443
Sell
|
9.4504
Sell
|
| MA50 |
9.4655
Sell
|
9.3797
Sell
|
| MA100 |
9.1518
Buy
|
9.234
Buy
|
| MA200 |
8.951
Buy
|
9.1793
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TBPH could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on TBPH, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 47.75 indicates that TBPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.69 indicates that TBPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 32.41 indicates that TBPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.01 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -9.2708 indicates that TBPH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TBPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Theravance Biopharma Inc financial reports and earnings history, Theravance Biopharma Inc (TBPH) stock could reach $8.4142 by 2030, $9.4437 by 2040 and $32.79 by 2050. See the projected annual prices until 2050 of the Theravance Biopharma Inc stock below:
- Theravance Biopharma Inc (TBPH) is expected to reach an average price of $1.4837 in 2035, with a high prediction of $2.7023 and a low estimate of $1.7837. This indicates an $-84.07% rise from the last recorded price of $9.315.
- Theravance Biopharma Inc (TBPH) stock is projected to chart a bullish course in 2040, with an average price target of $9.7592, representing an $4.77% surge from its current level. The forecast ranges from a conservative $9.2323 to a sky-high $9.4437.
- Our analysts predict Theravance Biopharma Inc (TBPH) to jump 125.26% by 2045, soaring from $21.07 to an average price of $20.98, potentially reaching $21.05. While $21.07 is the low estimate, the potential upside is significant.
- Theravance Biopharma Inc (TBPH) stock is expected to climb by 2050, reaching an average of $32.46, a $248.43% jump from its current level. However, a wide range of estimates exists, with high and low targets of $32.79 and $33.56, respectively, highlighting the market's uncertainty.
Theravance Biopharma Inc Stock (TBPH) Year by Year Forecast
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2025
Theravance Biopharma Inc Stock (TBPH) is expected to reach an average price of $11.80 in 2025, with a high prediction of $19.90 and a low estimate of $3.7073. This indicates an +26.72% rise from the last recorded price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $11.65 | $10.66 | $19.75 | +25.06% |
| April, 2025 | $10.76 | $5.2322 | $14.86 | +15.51% |
| May, 2025 | $15.41 | $9.2354 | $16.64 | +65.47% |
| June, 2025 | $16.04 | $14.25 | $19.90 | +72.17% |
| July, 2025 | $10.68 | $9.5583 | $17.10 | +14.63% |
| August, 2025 | $10.48 | $8.7425 | $11.77 | +12.53% |
| September, 2025 | $6.9267 | $6.6567 | $11.73 | -25.64% |
| October, 2025 | $6.257 | $5.4388 | $8.187 | -32.83% |
| November, 2025 | $3.9863 | $3.8213 | $7.6792 | -57.21% |
| December, 2025 | $8.2416 | $3.7073 | $9.8616 | -11.52% |
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2026
The predicted value for Theravance Biopharma Inc (TBPH) in 2026 is set at an average of $6.9567. Estimates vary from a peak of $12.78 to a trough of $1.1381, indicating an -25.32% surge from the present price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.8459 | $5.5309 | $9.3777 | -37.24% |
| February, 2026 | $9.0801 | $5.7719 | $9.6901 | -2.52% |
| March, 2026 | $7.6344 | $6.1433 | $8.9662 | -18.04% |
| April, 2026 | $8.5647 | $7.2604 | $10.75 | -8.05% |
| May, 2026 | $10.96 | $6.2608 | $11.06 | +17.65% |
| June, 2026 | $10.93 | $8.515 | $11.87 | +17.37% |
| July, 2026 | $8.8335 | $8.2035 | $12.78 | -5.17% |
| August, 2026 | $8.4178 | $6.2657 | $8.8096 | -9.63% |
| September, 2026 | $4.0581 | $3.9081 | $9.0738 | -56.43% |
| October, 2026 | $3.4424 | $3.1724 | $5.3624 | -63.05% |
| November, 2026 | $1.1434 | $1.4634 | $4.8105 | -87.73% |
| December, 2026 | $1.9031 | $1.1381 | $1.8891 | -79.57% |
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Theravance Biopharma Inc (TBPH) is $2.1613, with a high forecast of $4.30 and a low forecast of $0.0226. This indicates an -76.80% decrease from the last price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4888 | $1.6688 | $1.777 | -84.02% |
| February, 2027 | $0.7446 | $1.0206 | $1.0327 | -92.01% |
| March, 2027 | $1.7758 | $0.4758 | $2.2558 | -80.94% |
| April, 2027 | $1.01 | $0.39 | $4.30 | -89.16% |
| May, 2027 | $0.0643 | $0.1568 | $0.9061 | -99.31% |
| June, 2027 | $0.9746 | $0.1114 | $2.1146 | -89.54% |
| July, 2027 | $1.0289 | $0.5067 | $2.4667 | -88.95% |
| August, 2027 | $0.7331 | $0.3831 | $1.607 | -92.13% |
| September, 2027 | $0.9434 | $0.0226 | $2.1452 | -89.87% |
| October, 2027 | $0.4977 | $0.0423 | $1.1116 | -94.66% |
| November, 2027 | $1.1419 | $0.3198 | $1.8531 | -87.74% |
| December, 2027 | $1.6523 | $0.532 | $1.9541 | -82.26% |
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2028
In 2028, Theravance Biopharma Inc (TBPH) is projected to reach an average price of $3.0898, with a high projection of $5.1691 and a low estimate of $1.0105. This indicates an -66.83% fall from the last price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5165 | $1.0105 | $1.9383 | -83.72% |
| February, 2028 | $2.3908 | $1.1986 | $3.2247 | -74.33% |
| March, 2028 | $2.3511 | $1.889 | $2.5979 | -74.76% |
| April, 2028 | $3.0853 | $2.0422 | $4.289 | -66.88% |
| May, 2028 | $3.9157 | $2.8314 | $4.1157 | -57.96% |
| June, 2028 | $3.8149 | $3.0439 | $4.2399 | -59.05% |
| July, 2028 | $3.2042 | $3.1442 | $3.956 | -65.60% |
| August, 2028 | $3.1745 | $2.1524 | $3.7924 | -65.92% |
| September, 2028 | $3.9688 | $3.1166 | $4.4388 | -57.39% |
| October, 2028 | $4.493 | $3.8069 | $5.1409 | -51.77% |
| November, 2028 | $4.3833 | $3.7251 | $5.1691 | -52.94% |
| December, 2028 | $3.7476 | $3.3776 | $4.5594 | -59.77% |
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2029
The 2029 price forecast for Theravance Biopharma Inc Stock (TBPH) is $3.9771 on average, with a high prediction of $5.9156 and a low estimate of $2.0385. This represents an -57.30% decrease from the previous price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.4179 | $2.8918 | $4.0137 | -63.31% |
| February, 2029 | $3.0822 | $2.9122 | $3.96 | -66.91% |
| March, 2029 | $2.7364 | $2.5914 | $3.9164 | -70.62% |
| April, 2029 | $2.9007 | $2.0385 | $3.4185 | -68.86% |
| May, 2029 | $4.071 | $2.7667 | $5.171 | -56.30% |
| June, 2029 | $4.7253 | $3.9271 | $4.7553 | -49.27% |
| July, 2029 | $5.4195 | $4.5613 | $5.7234 | -41.82% |
| August, 2029 | $3.7898 | $3.6477 | $5.9156 | -59.31% |
| September, 2029 | $3.3941 | $2.572 | $3.8059 | -63.56% |
| October, 2029 | $3.4644 | $2.9383 | $4.5501 | -62.81% |
| November, 2029 | $3.9887 | $3.2205 | $5.0626 | -57.18% |
| December, 2029 | $4.0699 | $3.1208 | $4.2847 | -56.31% |
Theravance Biopharma Inc Stock (TBPH) Price Forecast for 2030
Theravance Biopharma Inc Stock (TBPH) is expected to reach an average price of $4.3015 in 2030, with a high forecast of $8.5949 and a low forecast of $0.00819. This signifies an -53.82% decrease from the last price of $9.315.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.7692 | $5.6577 | $8.4142 | +4.88% |
| February, 2030 | $7.8806 | $9.2428 | $8.5949 | -15.40% |
| March, 2030 | $4.6121 | $4.8621 | $6.7985 | -50.49% |
| April, 2030 | $2.9036 | $4.5379 | $4.18 | -68.83% |
| May, 2030 | $5.068 | $2.6572 | $4.893 | -45.59% |
| June, 2030 | $8.0045 | $6.2309 | $6.8366 | -14.07% |
| July, 2030 | $6.0738 | $7.0688 | $7.6323 | -34.80% |
| August, 2030 | $0.3247 | $2.0053 | $2.3667 | -96.51% |
| September, 2030 | $0.5032 | $0.00819 | $2.5268 | -94.60% |
| October, 2030 | $1.5738 | $0.0597 | $7.9617 | -83.10% |
| November, 2030 | $0.2223 | $0.6902 | $3.1971 | -97.61% |
| December, 2030 | $0.9691 | $1.9213 | $1.4366 | -89.60% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):